Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

The Ets1 proto-oncogene is upregulated by retinoic acid: characterization of a functional retinoic acid response element in the Ets1 promoter

Abstract

The v-ets oncoprotein and its progenitor Ets1 belong to a family of transcription factors that are related by an 85 amino acid conserved DNA binding domain, the ets domain. Ets1 plays important role(s) in control of cell proliferation, differentiation and apoptosis. Abnormal expression of Ets1 could lead to disruption of these processes and contribute to development of malignancy. Retinoic acid (RA) inhibits proliferation, induces differentiation and regulates apoptosis in many different cell types. Here, we demonstrate that RA treatment increases the expression of Ets1 mRNA, but not that of Ets2, Elk1 or Fli1 in MC3T3-E1 cells. Ets1 induction is detectable after 4 h, can be maintained for at least 14 days, and is inhibited by Actinomycin D, which suggests that RA regulation of Ets1 occurs at the transcriptional level. The promoter region of Ets1 contains four retinoic acid response element (RARE) half sites located at −94, −152, −1765 and −2252 from the translation start site. We show that RARβ is expressed by MC3T3-E1 cells in the presence of RA and demonstrate that it binds to the −94 RARE half site. Furthermore, RA induces transcription of Ets1 promoter-reporter constructs containing this RARE half site.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  • Bellacosa A, Datta K, Bear SE, Patriotis C, Lazo PA, Copeland NG, Jenkins NA and Tsichlis PN . 1994 J Virol 68: 2320–2330

  • Bhat NK, Fisher RJ, Fujiwara S, Ascione R and Papas TS . 1987 Proc Natl Acad Sci USA 84: 3161–3165

  • Chen Z, Fisher RJ, Riggs CW, Rhim JS and Lautenberger JA . 1997 Cancer Res 57: 2013–2019

  • Chomczynski P and Sacchi N . 1987 Anal Biochem 162: 156–159

  • Davidoff AN and Mendelow BV . 1994 Anticancer Res 14: 1199–1201

  • Ducy P, Zhang R, Geoffroy V, Ridall AL and Karsenty G . 1997 Cell 89: 747–754

  • Gilles F, Raes MB, Stehelin D, Vandenbunder B and Fafeur V . 1996 Exp Cell Res 222: 370–378

  • Glass CK, Devary OV and Rosenfeld MG . 1990 Cell 63: 729–738

  • Greenberg ME, Hermanowski AL and Ziff EB . 1986 Mol Cell Biol 6: 1050–1057

  • Hart AH, Corrick CM, Tymms MJ, Hertzog PJ and Kola I . 1995 Oncogene 10: 1423–1430

  • Hoosein NM, Brattain DE, McKnight MK, Childress KE, Chakrabarty S and Brattain MG . 1988 Cancer Lett 40: 219–232

  • Inoue A, Otsuka E, Hiruma Y, Hirose S, Furuya M, Tanaka S and Hagiwara H . 1996 Biochem Biophys Res Commun 228: 182–186

  • Janknecht R and Nordheim A . 1993 Biochim Biophys Acta 1155: 346–356

  • Jorcyk CL, Garrett LJ, Maroulakou IG, Watson DK and Green JE . 1997 Cell Mol Biol, Noisy-le-grand 43: 211–225

  • Jorcyk CL, Watson DK, Mavrothalassitis GJ and Papas TS . 1991 Oncogene 6: 523–532

  • Karperien M, Farih-Sips H, Lowik CW, de Laat SW, Boonstra J and Defize LH . 1997 Mol Endocrinol 11: 1434–1448

  • Kim WY, Sieweke M, Ogawa E, Wee HJ, Englmeier U, Graf T and Ito Y . 1999 EMBO J 18: 1609–1620

  • Kola I, Brookes S, Green AR, Garber R, Tymms M, Papas TS and Seth A . 1993 Proc Natl Acad Sci USA 90: 7588–7592

  • LaRosa GJ and Gudas LJ . 1988 Mol Cell Biol 8: 3906–3917

  • Lau LF and Nathans D . 1987 Proc Natl Acad Sci USA 84: 1182–1186

  • Leid M, Kastner P and Chambon P . 1992 Trends Biochem Sci 17: 427–433

  • Linney E . 1992 Curr Top Dev Biol 27: 309–350

  • Lohnes D, Mark M, Mendelsohn C, Dolle P, Dierich A, Gorry P, Gansmuller A and Chambon P . 1994 Development 120: 2723–2748

  • Mahadevan LC and Edwards DR . 1991 Nature 349: 747–748

  • Majerus MA, Bibollet-Ruche F, Telliez JB, Wasylyk B and Bailleul B . 1992 Nucleic Acids Res 20: 2699–2703

  • Mangelsdorf DJ, Borgmeyer U, Heyman RA, Zhou JY, Ong ES, Oro AE, Kakizuka A and Evans RM . 1992 Genes Dev 6: 329–344

  • Maroulakou IG, Papas TS and Green JE . 1994 Oncogene 9: 1551–1565

  • Niles RM, Wilhelm SA, Thomas P and Zamcheck N . 1988 Cancer Invest 6: 39–45

  • Oka T, Rairkar A and Chen JH . 1991 Oncogene 6: 2077–2083

  • Seth A, Ascione R, Fisher RJ, Mavrothalassitis GJ, Bhat NK and Papas TS . 1992 Cell Growth Differ 3: 327–334

  • Seth A and Papas TS . 1990 Oncogene 5: 1761–1767

  • Seth A, Watson DK, Blair DG and Papas TS . 1989 Proc Natl Acad Sci USA 86: 7833–7837

  • Sharrocks AD, Brown AL, Ling Y and Yates PR . 1997 Int J Biochem Cell Biol 29: 1371–1387

  • Sun W, Graves BJ and Speck NA . 1995 J Virol 69: 4941–4949

  • Suva LJ, Ernst M and Rodan GA . 1991 Mol Cell Biol 11: 2503–2510

  • Suva LJ, Towler DA, Harada S, Gaub MP and Rodan GA . 1994 Mol Endocrinol 8: 1507–1520

  • Suzuki H, Romano-Spica V, Papas TS and Bhat NK . 1995 Proc Natl Acad Sci USA 92: 4442–4446

  • Thiele CJ, Deutsch LA and Israel MA . 1988 Oncogene 3: 281–288

  • Wang DY, Yang VC and Chen JK . 1997 In Vitro Cell Dev Biol Anim 33: 248–255

  • Wasylyk B, Hahn SL and Giovane A . 1993 Eur J Biochem 211: 7–18

  • Watson DK, Ascione R and Papas TS . 1990 Crit Rev Oncog 1: 409–436

Download references

Acknowledgements

This work was supported by a Medical Research Council (Canada) group grant to A Seth.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Raouf, A., Li, V., Kola, I. et al. The Ets1 proto-oncogene is upregulated by retinoic acid: characterization of a functional retinoic acid response element in the Ets1 promoter. Oncogene 19, 1969–1974 (2000). https://doi.org/10.1038/sj.onc.1203505

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1203505

Keywords

This article is cited by

Search

Quick links